Sankyo Company, Ltd.
3-5-1, Nihonbashi Hon-Cho
Chuo-ku
Tokyo
103-8426
Tel: 03-5255-7111
Website: http://www.sankyo.co.jp/
16 articles about Sankyo Company, Ltd.
-
Hovione Licenses Inhaler Technology for Influenza Drug to Sankyo Company, Ltd. and Biota Holdings Limited
3/5/2007
-
Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection
10/2/2006
-
Ajinomoto And Sankyo Company, Ltd. In Joint Development, Manufacture And Marketing Of AJD101, New Diabetes Drug
8/31/2006
-
Sankyo To Manufacture, Distribute Olmetic Antihypertensive Drug In China
8/4/2006
-
Sankyo Company, Ltd. To Manufacture, Distribute Olmetic Antihypertensive Drug In China
8/2/2006
-
Sankyo Company, Ltd. To Launch Osteoporosis Treatment Drug In Europe
7/19/2006
-
Sankyo Company, Ltd. Selected Evotec OAI (Germany) As Assay Development And Screening Partner
4/27/2006
-
Exelixis, Inc. And Sankyo Company, Ltd. Sign Collaboration Agreement To Develop Novel Therapies For Cardiovascular Disease; $20 Million Upfront Payment
3/20/2006
-
MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies
3/16/2006
-
Eli Lilly and Company And Sankyo Company, Ltd. Release: Study Shows More Potent And More Reliable Platelet Inhibition wWth Prasugrel Compared To Clopidogrel Even In Patients With More Reactive Platelets
3/13/2006
-
Sankyo Company, Ltd. To Supply Hyperlipidemia Drug Pravastatin In US
2/20/2006
-
Metabasis Therapeutics, Inc. Reports On Sankyo Company, Ltd.'s Initiation Of A Multi-Center Phase 2b Clinical Trial Of CS-917 For The Treatment Of Type 2 Diabetes
2/1/2006
-
KAI Pharmaceuticals, Inc. And Sankyo Company, Ltd. Enter Global Alliance To Develop And Commercialize Novel Compounds For Cardiovascular Disease
1/9/2006
-
KAI Pharmaceuticals, Inc. And Sankyo Company, Ltd. Enter Global Alliance To Develop And Commercialize Novel Compounds For Cardiovascular Disease
1/9/2006
-
Daiichi Pharmaceutical (JPN) And Sankyo Company, Ltd. To Establish Joint Healthcare Business Company
11/28/2005
-
Kureha Chemical Industry's Proprietary Anti-Chronic Renal Failure Agent KREMEZIN Now Available In Korea
2/2/2005